{
  "url": "https://openlegislation.uk/draft-human-medicines-coronavirus-and-influenza-amendment-regulations-2022/introduction",
  "json_url": "https://openlegislation.uk/draft-human-medicines-coronavirus-and-influenza-amendment-regulations-2022/introduction.json",
  "legislation": "ukdsi/2022/9780348231885",
  "legislation_title": "The Human Medicines (Coronavirus and Influenza) (Amendment) Regulations 2022",
  "legislation_url": "https://openlegislation.uk/draft-human-medicines-coronavirus-and-influenza-amendment-regulations-2022",
  "path": "introduction",
  "kind": "introduction",
  "number": null,
  "heading": "Introductory text",
  "text": "Draft Regulations laid before Parliament and the Northern Ireland Assembly under section 47(3) and 6(c) of the Medicines and Medical Devices Act 2021, for approval by resolution of each House of Parliament and the Northern Ireland Assembly.\nMedicines\nMade ***\nComing into force ***\nThe Secretary of State in relation to England and Wales and Scotland, and the Secretary of State and the Department of Health in Northern Ireland acting jointly in relation to Northern Ireland, in exercise of the powers conferred by sections 2(1), 3(1)(a), (c), (d), (j), (n), (2)(a), (c) and (d) of the Medicines and Medical Devices Act 2021, and after having considered the matters in section 2(2) to (4) of that Act, make the following Regulations.\nThe Secretary of State and the Department of Health in Northern Ireland make these Regulations having carried out a public consultation, in accordance with section 45(1) of that Act.\nIn accordance with section 47(3) and (6)(c) of that Act, a draft of the instrument was laid before Parliament and the Northern Ireland Assembly, and approved by a resolution of each House of Parliament and the Northern Ireland Assembly.",
  "extent": null,
  "status": null,
  "version": "current",
  "annotations": [
    {
      "type": "footnote",
      "label": "f1",
      "text": "Section 2(1) is exercisable by the “appropriate authority”, and in relation to England and Wales and Scotland, this means the Secretary of State, as defined in section 2(6)(a) of the Medicines and Medical Devices Act 2021."
    },
    {
      "type": "footnote",
      "label": "f2",
      "text": "Section 2(1) is exercisable by the “appropriate authority”, and in relation to Northern Ireland, this can mean the Department of Health in Northern Ireland and the Secretary of State acting jointly, as defined in section 2(6)(b)(ii) of the Act."
    },
    {
      "type": "footnote",
      "label": "f3",
      "text": "The “law relating to human medicines” is defined in section 9 of the Act."
    },
    {
      "type": "footnote",
      "label": "f4",
      "text": "2021 c. 3."
    }
  ],
  "outstanding_effects": [],
  "provenance": {
    "source": "legislation.gov.uk",
    "source_url": "https://www.legislation.gov.uk/ukdsi/2022/9780348231885/introduction",
    "retrieved_at": "2026-10-30T14:45:51.556481+00:00"
  },
  "licence": "Open Government Licence v3.0",
  "licence_url": "https://www.nationalarchives.gov.uk/doc/open-government-licence/version/3/",
  "attribution": "Contains public sector information licensed under the Open Government Licence v3.0. Source: legislation.gov.uk, The National Archives."
}